City

Boston (1)

Nanjing (1)

Condition

Advanced Head and Neck Cancer (2)

Advanced Head and Neck Squamous Cell Carcinoma (1)

Metastatic Head and Neck Cancer (1)

Recurrent Squamous Cell Carcinoma of the Head and Neck (1)

Squamous Cell Carcinoma of the Head and Neck (SCCHN) (1)

Overall Status

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Glenn J. Hanna (1)

Shenzhen SiBiono GeneTech Co.,Ltd (1)

Collaborator

Secura Bio, Inc. (1)

Intervention

cisplatin (1)

docetaxel (1)

duvelisib (1)

rad-p53 (1)

radiation (1)

Study Documents

Intervention Type

drug (2)

radiation (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

advanced head and neck cancer

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Squamous Cell Carcinoma of the Head and Neck (SCCHN), Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Head

Recruiting

Squamous Cell Carcinoma of the Head and Neck (SCCHN)
+4 more

Boston, Massachusetts

Dana Farber Cancer Institute

Jan 19, 2023

Advanced Head Neck Cancer Trial in Nanjing (rAd-p53, radiation, Cisplatin)

Unknown status

Advanced Head and Neck Cancer

rAd-p53
+2 more

Nanjing, Jiangsu, China

Jiangsu cancer hospital

Apr 23, 2015